Mchem of A/P/G/G Flashcards
1
Q
Psoriasis Treatment
External
A
- Calcipotriene, Vitamin A analog, Anthralin
- AhR Agonist
- Photo(chemo)therapy - PUVA
- Corticosteroids
- Calcineurin inhibitors
2
Q
Psoriasis treatment
Systemic
A
- Methotrexate
- Oral Retinoids
- PDE4 Inhibitors
- Biologics
3
Q
Calcipotriene
A
- synthetic Vitamin D3 deriv
- Does not cause Tachyphylaxis
- minimally absorbed systemically
4
Q
Vitamin D3 Receptor Signaling
A
- Inhibits expresion of inflammatory cytokines
- inhibits T-cell proliferation and induces T-regulatory cells
- supresses proliferation of keratinocytes
5
Q
Acetylenic
Tazarotene
A
- Prodrug
- Rigid non-isomerizatable retinoid
- Limits systemic toxicity (rapid systemic metabolic inactivation)
- Selective to RAR-beta and -gamma
6
Q
All Trans Retinoic Acid (ATRA)
A
- Flexible due to alternate db
- double bonds undergo cis/trans-isomerization
- lose selectivity once isomerized
7
Q
Which RAR’s are pre-dominantly on the skin?
A
Beta and gamma
8
Q
Anthralin
A
- Inhibits DNA synthesis
- Very unstable (C10 oxidation)
- Prepared with antioxidants
9
Q
Tapinarof
A
- Structural analog of Resveratrol
- Anti-inflammatory
- Anti-oxidant
- develop and maintain skin barrier
10
Q
Aryl Hydrocarbon Receptor (AhR)
A
- widely expressed in the skin
- cystolic ligand-activated transcription factor
11
Q
Photochemotherapy
Methoxsalen
A
- For severe psoriasis
- photoactive substance
- Upon UV exposure, double bonds become reactive
12
Q
MOA
Methoxsalen
A
- Decreased DNA Synthesis
- Free radical-mediated covalent modification of thymine on DNA
13
Q
Etretinate
A
- Tretinoin analog
- Nonselective
- First-pass metabolism to make active metabolite (acitretin)
- accumulates in adipose tissue after repeat dosing (120 day half-life)
14
Q
MOA
Apremilast
A
- PDE4 Inhibitor
- Orally active, Non-selective
- increase cAMP = decrease pro-inflammatory cytokine
- increase anti-inflammatory cytokine
15
Q
Biologics
Alefacept
A
- Inhibit T-cell activation
- binds to CD2 on T-cell
- IM injection
16
Q
Biologic
Efalizumab
A
- inhibit T-cell activation
- mAb target LFA1
- Subq injection
17
Q
Biologic
Ustekinumab
A
- mAb
- Inhibit IL-12 and IL-23 (p40 subunit)
- Subq injection
18
Q
Biologic
Ixekizumab
A
- Anti-IL-17A mAb
- Moderate - severe plague psoriasis
19
Q
Acne
Treatment Goals
A
- Correct abnormalities of follicle maturation
- Decrease sebum production + P.acne colonization
- Decrease inflammation
20
Q
Acne
Drugs Used
A
- SA
- Benzoyl Peroxide
- Tretinoin
- Isotretinoin
- Azelaic Acid
- Adapalene
- Trifarotene
- Antibiotics